Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Parkinson Disease

Neurocrine Biosciences Presents Positive Data From BIPARK-1 and -2 Studies of Opicapone for Parkinson’s Disease

Neurocrine Biosciences announced data analysis from two phase 3 trials evaluating opicapone added to levodopa for Parkinson’s disease was presented […]

Parkinson Disease
2 years ago
Share

Tel Aviv University Researchers Study Parkinson’s Challenge with Transitions from Walking to Sitting

Israeli researchers from Tel Aviv University found that when healthy older adults turn to sit, about 80% of them complete […]

Parkinson Disease
2 years ago
Share

Prominent Couple Give $15 Million to Washington Univ. to Neurodegenerative Disease Test Therapies

A prominent couple (Rodger and Paula Riney) have made a $15 million gift to Washington University of Medicine, St. Louis. […]

Neurodegenerative Disease
2 years ago
Share

CUHK Study Reveals RBD Patients’ First-Degree Relatives More Likely to Have Parkinson’s Disease

Researchers from Chinese University Hong Kong (CUHK) report that people with first-degree relatives suffering from rapid eye movement sleep behavioral […]

Parkinson Disease
2 years ago
Share

Pharma Watch: Servier and Oncodesign Partner to Investigate New Line of Research

France-based Servier and Oncodesign have agreed to partner on the development of LRRK2 kinase inhibitors in Parkinson’s disease. Servier to […]

partners
2 years ago
Share

MJFF & Silverstein Foundation Jointly Award $3 Million Supporting GBA Mutation Research

The Michael J. Fox Foundation and Silverstein Foundation for Parkinson’s with GBA teamed up to provide funding to leverage resources […]

2 years ago
Share

Pioneering Parkinson’s Disease Trials Program Funded by Parkinson’s UK

Parkinson’s UK is funding a pioneering clinical trials program. It centers on investigational treatment directly to the brain. The sponsor’s […]

2 years ago
Share

UT Southwestern Deepening Parkinson’s Disease Expertise

Dallas News reports that UT Southwestern has hired well-known neurologist Dr. William T. Dauer. He will lead the Peter O’Donnell […]

2 years ago
Share

Australian Parkinson’s Program Integrating Genomics with Clinical Trials Receives $30 Million

As reported by UNSW Sydney Newsroom, the Australian Parkinson’s Mission, an innovative program combining clinical trials with genomics research for […]

Genomics
2 years ago
Share

University of Utah Study: Association Between ADHD and Parkinson’s-Related Disorders

As reported in Neurology Today’s by Olga Rukovets, the likelihood of developing a Parkinson’s disease-related movement disorder was two to three […]

2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.